Federico Scolari
Florence, 50139, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study.
Journal: Scientific reports
Published: April 06, 2026
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.
Journal: Frontiers in immunology
Published: February 26, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.
Journal: Clinical genitourinary cancer
Published: January 14, 2026
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer.
Journal: Metabolites
Published: November 13, 2025
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Journal: Cancer immunology, immunotherapy : CII
Published: October 14, 2025
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study.
Journal: In vivo (Athens, Greece)
Published: August 09, 2025
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma.
Journal: Cell death & disease
Published: August 08, 2025
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC.
Journal: Frontiers in oncology
Published: June 26, 2025
Periacetabular Resection for Bone Tumors: Is There Still a Role for Massive Allograft-prosthesis Composite Reconstructions?
Journal: Clinical orthopaedics and related research
Published: June 20, 2025
Last Updated: 09/26/2026